Download PDF
1 / Pages

Other users also viewed these articles

Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease Guillermo Nahúm López-Sánchez; Mayra Dóminguez-Pérez; Misael Uribe; Norberto Carlos Chávez-Tapia; Natalia Nuño-Lámbarri;
10.1016/j.aohep.2020.04.012
Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? Diego García-Compeán; Jesús Zacarías Villarreal-Pérez; Manuel Enrique de la O. Cavazos; Fernando Javier Lavalle-Gonzalez; Omar David Borjas-Almaguer; Angel Noé Del Cueto-Aguilera; José Alberto González-González; Consuelo Treviño-Garza; Lourdes Huerta-Pérez; Héctor Jesús Maldonado-Garza;
Ann Hepatol. 2020;19:258-64
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;
Ann Hepatol. 2024;29: